Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming Deadlines in Shareholder Litigation Involving Groupon (GRPN), Isis Pharmaceuticals (ISIS) and Silvercorp Metals (SVM)


Print article Print article
© Marketwire 2013
2013-01-25 18:47:50 -

ATLANTA, GA -- (Marketwire) -- 01/25/13 -- Holzer Holzer & Fistel, LLC reminds investors of upcoming deadlines for applications to serve as lead plaintiff in securities class action lawsuits against Groupon, Inc. (NASDAQ: GRPN), Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and Silvercorp Metals, Inc. (NYSE: SVM).



Investors that suffered significant losses investing in any of these companies who are interested in potentially serving as lead plaintiff in the respective class actions are encouraged to contact Michael I. Fistel, Jr., Esq. ( mfistel@holzerlaw.com : mailto:mfistel@holzerlaw.com ) or Marshall P. Dees, Esq. ( mdees@holzerlaw.com : mailto:mdees@holzerlaw.com ) by email or via toll-free telephone at (888) 508-6832 to discuss their legal rights.





Groupon, Inc.



A class action lawsuit has been filed on behalf of investors who purchased Groupon, Inc. common stock between May 14, 2012 and November 8, 2012, inclusive, alleging the company violated the federal securities laws by making false and misleading statements relating to its revenue and growth.



The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the Northern District of Illinois, is February 19, 2013. More information about the lawsuit and the firm are available at www.holzerlaw.com : ctt.marketwire.com/?release=978509&id=2525572&type=1& .. .



Isis Pharmaceuticals, Inc.



A class action lawsuit has been filed on behalf of investors who purchased Isis Pharmaceuticals, Inc.'s securities between March 29, 2012 and October 15, 2012. The lawsuit alleges the company violated the federal securities laws by failing to adequately disclose issues with its experiential drug Kynamro.



The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the Southern District of California, is February 26, 2013. More information about the lawsuit and the firm are available at www.holzerlaw.com : ctt.marketwire.com/?release=978509&id=2525575&type=1& .. .



Silvercorp Metals, Inc.



A class action lawsuit has been filed on behalf of investors who purchased Silvercorp Metals, Inc. common stock between June 24, 2010 and September 13, 2011. According to the complaint, the company is alleged to have violated the federal securities laws by issuing false and misleading statements regarding the level of silver production at its mines and the quality and quantity of its ore reserves.



The deadline to seek appointment as lead plaintiff in this lawsuit, which is pending in the United States District Court for the Southern District of New York, is March 1, 2013. More information about the lawsuit and the firm are available at www.holzerlaw.com : ctt.marketwire.com/?release=978509&id=2525578&type=1& .. .



About The Firm



Holzer Holzer & Fistel, LLC dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com : ctt.marketwire.com/?release=978509&id=2525581&type=1& .. and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com